CHC LABS INC.
|
HEPATITIS B SURFACE ANTIBODY AND SURFACE ANTIGEN (86706,87340) |
|
|
Antibody |
|
|
070.20-070.23 |
Viral hepatitis B with hepatic coma |
|
070.30-070.33 |
Viral hepatitis B without mention of hepatic coma |
|
403.01 |
Malignant hypertensive renal disease with renal failure |
|
403.11 |
Benign hypertensive renal disease with renal failure |
|
404.02 |
Malignant hypertensive heart and renal disease with renal failure |
|
404.03 |
Malignant hypertensive heart and renal disease with heart failure and renal failure |
|
404.12 |
Benign hypertensive heart and renal disease with renal failure |
|
404.13 |
Benign hypertensive heart and renal disease with heart failure and renal failure |
|
585 |
Chronic renal failure |
|
V01.7 |
Contact with or exposure to other viral diseases (viral hepatitis) |
|
V05.3 |
Need for other prophylactic vaccination and inoculation against single diseases, Viral hepatitis |
|
V45.1 |
Renal dialysis status |
|
V67.59 |
Follow-up examination, other treatment [Hepatitis B Vaccination] |
|
Antigen |
|
|
070.20-070.23 |
Viral hepatitis B with hepatic coma |
|
070.30-070.33 |
Viral hepatitis B without mention of hepatic coma |
|
070.6 |
Unspecified viral hepatitis with hepatic coma |
|
070.9 |
Unspecified viral hepatitis without mention of hepatic coma (fulminant hepatic failure) |
|
403.01 |
Malignant hypertensive renal disease with renal failure |
|
403.11 |
Benign hypertensive renal disease with renal failure |
|
404.02 |
Malignant hypertensive heart and renal disease with renal failure |
|
404.03 |
Malignant hypertensive heart and renal disease with heart failure and renal failure |
|
404.12 |
Benign hypertensive heart and renal disease with renal failure |
|
404.13 |
Benign hypertensive heart and renal disease with heart failure and renal failure |
|
446.0 |
Polyarteritis nodosa |
|
570 |
Acute and subacute necrosis of liver |
|
573.1 |
Hepatitis in viral diseases classified elsewhere |
|
573.2 |
Hepatitis in other infectious diseases classified elsewhere |
|
573.3 585 |
Hepatitis, unspecified Chronic renal failure |
|
719.40-719.49 |
Pain in joint (arthralgia) |
|
729.1 |
Myalgia and myositis, unspecified |
|
774.4 |
Perinatal jaundice due to hepatocellular damage |
|
780.6 |
Fever (of unknown origin) |
|
780.79 |
Other malaise and fatigue |
|
782.1 |
Rash and other nonspecific skin eruption |
|
782.4 |
Jaundice, unspecified, not of newborn |
|
783.0 |
Anorexia |
|
787.02 |
Nausea alone |
|
789.1 |
Hepatomegaly |
|
790.4 |
Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] |
|
791.9 |
Other nonspecific findings on examination of urine (urobilin or urochrome) |
|
792.1 |
Nonspecific abnormal findings in stool contents |
|
V01.7 |
Contact with or exposure to other viral diseases (viral hepatitis) |
|
V02.61 |
Hepatitis B carrier |
|
V45.1 |
Renal dialysis status |
Note: Billing for Hepatitis B Surface Antigen for ESRD beneficiaries requires dual diagnoses. Please submit codes 403.01,403.11,404.02,404.03,404.12,404.13, or 585 and V45.1 to report the approved indication.
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|